Abstract
In 1973, we proposed a hypothesis of atherogenesis35 that provided a basis for the design of in vivo and in vitro experiments to determine how the advanced proliferative smooth muscle lesions of atherosclerosis form. Three fundamental biologic phenomena comprise the advanced lesions of atherosclerosis and lead to the development of occlusive lesions. Understanding why and how each of these phenomena occurs is fundamental to the development of this hypothesis. These phenomena are: (1) the accumulation of large numbers of intimal cells, principally proliferated smooth muscle together with numerous macrophages derived from blood monocytes; (2) formation by the proliferated smooth muscle cells of connective tissue matrix macromolecules including collagen, elastic fibers, and proteoglycans; and (3) accumulation of lipid both within the accumulated smooth muscle cells and macrophages, and within the components of the extracellular matrix. Any hypothesis of atherogenesis must take into account these phenomena, and should afford the opportunity to devise experiments to test the various components of the hypothesis
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Assoian, R. K., and Sporn, M. B., 1986, Type p transforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells, J. Cell. Biol. 102:1217–1223.
la. Assoian, R. K., Fleurdelys, B. E., Stevenson, H. C., Miller, P. J., Madtes, D. K., Raines, E. W., Ross, R., and Sporn, M. D., 1987, Expression and secretion of type (3 transforming growth factor by activated human macrophages, Proc. Nat. Acad. Sci. USA 84:6020-6024.
Baird, A., Morm£de, P., and Bohlen, P., 1985,Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor, Biochem. Biophys. Res. Commun. 126:358–364.
Barrett, T. B., Gajdusek, C. M., Schwartz, S. M., McDougall, J. K., and Benditt, E. P., 1984, Expression of the sis gene by endothelial cells in culture and in vivo, Proc. Natl. Acad. Sci. USA 81:6772-6774.
Baumgartner, H. R., and Studer, A., 1966, Folgen des gefasskatheterismus am normo-und hypercholesterinaemischen kaninchen, Pathol. Microbiol. 29:393–405.
Bevilacqua, M. P., Pober, J. S., Cotran, R. S., and Gimbrone, M. A., Jr., 1985, Interleukin 1 (IL-1) acts upon vascular endothelium to stimulate procoagulant activity and leukocyte adhesion, J. Cell. Biochem. Suppl. 9A:148 (abstract).
Bitteman, P. B., Rennard, S. I., Hunninghake, G. W., and Crystal, R. G., 1982, Human alveolar macrophage growth factor for fibroblasts: Regulation and partial characterization, J. Clin. Invest. 70:806–822.
Cathcart, M. K., Morel, D. W., and Chisolm, G. M., III, 1985, Monocytes and neutrophils oxidize low-density lipoprotein making it cytotoxic, J. Leukocyte Biol. 38:341–350.
Chobanian, A. V., Brecher, P. I., and Haudenshild, C. C., 1986, Effects of hypertension and of antihypertension therapy on atherosclerosis: State of the Art Lecture, in: Inter-American Society Proceedings, Suppl. I 8:15–21.
DiCorleto, P. E., and Bowen-Pope, D. F., 1983, Cultured endothelial cells produce a plateletderived growth factor-like protein, Proc. Natl. Acad. Sci. USA 80:1919-1923.
DiCorleto, P. E., and de la Motte, C. A., 1985, Characterization of the adhesion of the human monocytic cell line U-937 to cultured endothelial cells, J. Clin. Invest. 75:1153–1161.
Dinarello, C. A., 1984, Interleukin-1, Rev. Infect. Dis. 6:51–95.
Faggiotto, A., and Ross, R., 1984, Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque, Arteriosclerosis 4:341–356.
Faggiotto, A., Ross, R., and Harlan, L., 1984, Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation, Arteriosclerosis 4:323–340.
Gajdusek, C., DiCorleto, P., Ross, R., and Schwartz, S. M., 1980, An endothelial cell-derived growth factor, Cell. Biol. 85:467–472.
Gerrity, R. G., 1981, The role of the monocyte in atherogenesis. I. Transition of blood borne monocytes into foam cells in fatty lesions, Am. J. Pathol. 103:181–190.
Gerrity, R. G., 1981, The role of the monocyte in atherogenesis. II. Migration of foam cells from atherosclerotic lesions, Am. J. Pathol. 103:191–200.
Glenn, K. C., and Ross, R., 1981, Humn monocyte-derived growth factor(s) for mesenchymal cells: Activation of secretion by endotoxin and concanavalin A, Cell 25:603–615.
Harker, L. A., Ross, R., Slichter, S. J., and Scott, C. R., 1976, Homocystine-induced atherosclerosis: The role of endothelial cell injury and platelet response in its genesis,J. Clin. Invest. 58:731–741.
Heldin, C.-H., and Westermark, B., 1984, Growth factors: mechanism of action and relation to oncogenes, Cell 37:9–20.
Jerome, W. G., and Lewis, J. C., 1984, Early atherogenesis in White Carneau pigeons. I. Leukocyte margination and endothelial alterations at the celiac bifurcation, Am. J. Pathol. 116:56–68
Joris, J., Zand, T., Nunnary, J. L., Krolikowski, F. J., and Majno, G., 1983, Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats, Am. J. Pathol. 113:341–358.
Kohler, N., and Lipton, A., 1974, Platelete as a source of fibroblast growth-promoting activity, Exp. Cell Res. 87:297–301.
Leibovich, S. J., and Ross, R., 1976, A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro, Am. J. Pathol. 84:501–513.
Lewis, J. C., Taylor, R. G., Jones, N. D., St. Clair, R. W., and Cornhill, J. R., 1982, Endothelial surface characteristics in pigeon coronary artery atherosclerosis. I. Cellular alterations during the initial stages of dietary cholesterol challenge, Lab. Invest. 46:123–138.
Madtes, D. K., Raines, E. W., Sakariassen, K. S., Assoian, R. K., Sporn, M. B., Bell, G. I., and Ross, R. 1988, Induction of transforming growth factor alpha in activated human alveolar macrophages, Cell (in press).
Martin, B. M., Gimbrone, M. A., Unanue, E. R., and Cotran, R. S., 1981, Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor, J. Immunol. 126:1510–1515.
Martinet, Y., Bitterman, P. B., Mornex, J.-F., Grotendorst, G. R., Martin, G. R., and Crystal, R. G., 1986,Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity, Nature 319:158–160.
Mazzone, T., Jensen, M., and Chait, A., 1983, Human arterial wall cells secrete factors that are chemotactic for monocytes, Proc. Natl. Acad. Sci. USA 80:5094-5097.
Nathan, C. F., Murray, H. W., and Cohn, Z. A., 1980, Current concepts: The macrophage as an effector cell, N. Engl. J. Med. 303:622–626.
Nilsson, J., Sjolund, M., Palmberg, L., Thyberg, J., and Heldin, C.-H., 1985, Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein, Proc. Natl. Acad. Sci. USA 82:4418-4422.
Oka, Y., and Orth, D. N., 1983, Human plasma epidermal growth factor/p-urogastrone is associated with blood platelets, J. Clin. Invest. 72:249–259.
Report of the Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute, 1981, Volume 2, Government Printing Office, Washington, D.C. [DHEW Publ. No. (NIH) 82-2035].
Rosenfeld, M. E., Faggiotto, A., and Ross, R., 1985, The role of the mononuclear phagocyte in primate and rabbit models of atherosclerosis, in: Proceedings of the Fourth Leiden Conference on Mononuclear Phagocytes, Nijhoff, The Hague, pp 795–802.
Ross, R., 1981, Atherosclerosis—A problem of the biology of arterial wall cells and their interaction with blood components, Arteriosclerosis 1:293–311.
Ross, R., 1986, The pathogenesis of atherosclerosis—An update, N. Engl. J. Med. 314:488–500.
Ross, R., and Glomset, J. A., 1973, Atherosclerosis and the smooth muscle cell, Science 180:1332–1339.
Ross, R., and Glomset, J. A., 1976, The pathogenesis of atherosclerosis, N. Engl. J. Med. 295:369–377, 420-425.
Ross, R., Glomset, J., Kariya, B., and Harker, L., 1974, A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro, Proc. Natl. Acad. Sci. USA 71:1207-1210.
Ross, R., and Harker, L., 1976, Hyperlipidemia and atherosclerosis, Science 193:1094–1100.
Ross, R., Raines, E. W., and Bowen-Pope, D. F., 1986, The biology of platelet-derived growth factor, Cell 46:155–169.
Ross, R., Wight, T. N., Strandness, E., and Theile, B., 1984, Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery, Am. J. Pathol. 114:79–93.
Seifert, R. A., Schwartz, S. M., and Bowen-Pope, D. F., 1984, Developmentally regulated production of platelet-derived growth factor-like molecules, Nature 311:669–671.
Shimokado, K., Raines, E. W., Madtes, D. K., Barrett, T. B., Benditt, E. P., and Ross, R., 1985, A significant part of macrophage-derived growth factor consists of at least two forms of PDGF, Cell 43:277–286.
Stemerman, M. B., and Ross, R., 1972, Experimental atherosclerosis. I. Fibrous plaque formation in primates, an electron microscope study, J. Exp. Med. 136:769–789.
Stiles, C. D., 1983, The molecular biology of platelet-derived growth factor, Cell 33:653–655.
Walker, L. N., Bowen-Pope, D. F., Ross, R., and Reidy, M. A., 1986, Production of PDGF-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury, Proc. Natl. Acad. Sci. USA 83:7311-7315.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Ross, R. (1988). Endothelial Injury and Atherosclerosis. In: Simionescu, N., Simionescu, M. (eds) Endothelial Cell Biology in Health and Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0937-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0937-6_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8254-9
Online ISBN: 978-1-4613-0937-6
eBook Packages: Springer Book Archive